Hospira Injection Recall Issued Due to Particulate Matter
One lot of Hospira’s sodium chloride injection has been recalled following a consumer complaint of particulate matter, which could pose serious and potentially life-threatening heath risks.
A Hospira .09%Sodium Chloride Injection recall was announced by the FDA on April 26, after four different contaminants were identified within the injection solutions following testing of four individual containers.
The Hospira injection contamination that was identified within the fluid consisted of polyester fiber, nylon fiber, cotton fiber, and nitrocellulose fiber.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
The injections were originally recalled in August 2012, and this notice was a re-announcement of the action. However, Hospira Inc. has not received any reports of adverse consequences reported in relation to the solutions.
The recall consists of .09% Sodium Chloride Injection 100 ml in flexible containers with lot number 05-201-JT. The recalled fluids were manufactured by Hospira Inc. and have an expiration date of May 1, 2013. The product was distributed to the following states to wholesalers, distributors, hospitals, and pharmacies: Alaska, Alabama, Arizona, California, Colorado, Florida, Georgia, Hawaii, Iowa, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Maryland, Michigan, Missouri, Mississippi, North Carolina, North Dakota, New Jersey, New Mexico, New York, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia, Washington, Wisconsin, West Virginia and Wyoming
Use of the contaminated fluids may cause several health consequences such as local inflammation, phlebitis, or weakened immune systems. The risk to the consumer is heightened if the bacteria travels throughout the body and causes inflammation in the lungs.
Consumers have been advised to stop using and distributing the product immediately and contact Stericycle at 1-888-597-9582 where they will inform the consumer to quarantine any remaining inventory until they can arrangement to remove and replace the product.
"*" indicates required fields
More Top Stories
A new report highlights how many women and families feel left out of Camp Lejeune settlement negotiations after suffering repeated miscarriages they say were caused by miscarriages on the North Carolina military base.
A Bard Infuse-A-Port lawsuit claims a piece of a failed port catheter broke off, causing a woman to suffer a pulmonary embolism which has resulted in fragments of the device remaining in her heart.
A Wegovy gastroparesis lawsuit blames the weight loss drug for a stomach paralysis problems which left a woman with permanent injuries.